Cardiometabolic heart failure with preserved ejection fraction: from molecular signatures to personalized treatment
Abstract Heart failure with preserved ejection fraction (HFpEF) represents nearly half of all heart failure cases globally. The increased prevalence of cardiometabolic disease, driven by unhealthy lifestyles, has led to a growing population of people developing the so called “cardiometabolic HFpEF (...
Saved in:
| Main Authors: | Era Gorica, Martin A. Geiger, Ludovica Di Venanzio, Natalia Atzemian, Jan Alphard Kleeberger, Dominique Grigorian, Alessia Mongelli, Besa Emini Veseli, Shafeeq A. Mohammed, Frank Ruschitzka, Andreas J. Flammer, David Niederseer, Sarah Costantino, Francesco Paneni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Cardiovascular Diabetology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12933-025-02774-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of sacubitril/valsartan in different forms of heart failure
by: Mohammad Abumayyaleh, et al.
Published: (2025-06-01) -
Multiparity induces persistent myocardial structural, functional and transcriptomic remodelling in mice
by: Ruth R. Magaye, et al.
Published: (2025-07-01) -
Carbohydrate antigen-125 (CA125): a marker of right ventricular dysfunction and poor prognosis in heart failure with preserved ejection fraction
by: Sher May Ng, et al.
Published: (2025-10-01) -
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
by: Mark Sweeney, et al.
Published: (2020-09-01) -
Correction: Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis
by: Wanqian Yu, et al.
Published: (2025-07-01)